Although tumor-infiltrating lymphocyte density, particularly that of infiltrating CD8+ T cells, is strongly associated with ICB response in several cancer types [9, 48], this has not been rigorously evaluated in GC. The gene discussed is CD8A; the disease is neoplasm.